Keyphrases
In Cancer
100%
PARP Inhibitor (PARPi)
100%
Structure-activity Relationship
9%
Cell Apoptosis
9%
DNA Damage
9%
Breast Cancer
9%
Antitumor Effect
9%
Tumor Cells
9%
Cell Behavior
9%
Antitumor Activity
9%
Tumor Cell Apoptosis
9%
Functional Mechanism
9%
Biological Function
9%
Gene Transcription
9%
Ovarian Cancer
9%
Drug Resistance
9%
DNA Repair Genes
9%
DNA Repair
9%
Structure Feature
9%
Genome Stability
9%
Rucaparib
9%
PARP Family
9%
ADP-ribose
9%
Niraparib
9%
DNA Repair Enzymes
9%
Matched Molecular Pair Analysis
9%
Olaparib
9%
BRCA1, BRCA2
9%
Talazoparib
9%
Hematotoxicity
9%
Medicine and Dentistry
Malignant Neoplasm
100%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
100%
Programmed Cell Death
18%
Tumor Cell
18%
DNA Repair
18%
Breast Cancer
9%
Structure-Activity Relationship
9%
Antineoplastic Activity
9%
Antiinfective Agent
9%
Poly ADP Ribose Polymerase
9%
Drug Resistance
9%
Biological Functions
9%
Cell Function
9%
DNA Damage
9%
Genomic Instability
9%
BRCA1
9%
Genetic Transcription
9%
Adenosine Diphosphate Ribose
9%
Niraparib
9%
Rucaparib
9%
Olaparib
9%
Talazoparib
9%
DNA Repair Protein
9%
Ovarian Cancer
9%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
100%
Neoplasm
18%
Structure Activity Relationship
9%
Antiinfective Agent
9%
Ovary Cancer
9%
Breast Cancer
9%
Antitumor Activity
9%
Drug Resistance
9%
Rucaparib
9%
Talazoparib
9%
Olaparib
9%
Adenosine Diphosphate Ribose
9%
Niraparib
9%